Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
The present review details a chronological description of the events that took place during
the development of mesoporous materials, their different synthetic routes and their use as …
the development of mesoporous materials, their different synthetic routes and their use as …
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
K Mitusova, OO Peltek, TE Karpov… - Journal of …, 2022 - Springer
Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …
therapy, currently, there is no significant progress in the treatment of different types of brain …
Nanomaterials for diagnosis and treatment of brain cancer: Recent updates
Brain tumors, especially glioblastoma, remain the most aggressive form of all the cancers
because of inefficient diagnosis and profiling. Nanostructures, such as metallic …
because of inefficient diagnosis and profiling. Nanostructures, such as metallic …
Inorganic nano-drug delivery systems for crossing the blood–brain barrier: Advances and challenges
Q Tan, S Zhao, T Xu, Q Wang, M Zhang, L Yan… - Coordination Chemistry …, 2023 - Elsevier
The blood–brain barrier (BBB) exists between plasma and brain tissue. It comprises a
capillary wall and glial cells and prevents external substances, including therapeutic agents …
capillary wall and glial cells and prevents external substances, including therapeutic agents …
Blood-brain delivery methods using nanotechnology
Pathologies of the brain, of which brain cancer, Alzheimer's disease, Parkinson's disease,
stroke, and multiple sclerosis, are some of the most prevalent, and that presently are poorly …
stroke, and multiple sclerosis, are some of the most prevalent, and that presently are poorly …
Advancements in nanotherapeutics for Alzheimer's disease: current perspectives
Objectives Considerable progress has been made in the treatment of Alzheimer's disease
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
Q Ouyang, Y Meng, W Zhou, J Tong… - Journal of drug …, 2022 - Taylor & Francis
Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide and its
incidence is increasing due to the ageing population. Currently, the main limitations of AD …
incidence is increasing due to the ageing population. Currently, the main limitations of AD …
A reevaluation of chitosan-decorated nanoparticles to cross the blood-brain barrier
The blood-brain barrier (BBB) is a sophisticated and very selective dynamic interface
composed of endothelial cells expressing enzymes, transport systems, and receptors that …
composed of endothelial cells expressing enzymes, transport systems, and receptors that …
Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery
Introduction Epilepsy, a major neurological disorder affects about 1% of the Indian
population. The discovery of noninvasive strategies for epilepsy presents a challenge for the …
population. The discovery of noninvasive strategies for epilepsy presents a challenge for the …
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
M Beygi, F Oroojalian, S Azizi‐Arani… - Advanced Functional …, 2024 - Wiley Online Library
The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed
with tight junctions and adherent junctions that regulates the transport of various materials …
with tight junctions and adherent junctions that regulates the transport of various materials …